[1]黄伟东,廖佳,潘柄丞,等.髓三脏汤治疗肝肾阴虚型绝经后骨质疏松症的临床疗效评价[J].中国中医骨伤科杂志,2024,32(11):11-15+20.[doi:10.20085/j.cnki.issn1005-0205.241103]
　HUANG Weidong,LIAO Jia,PAN Bingcheng,et al.Clinical Efficacy of Suisanzang Decoction in Treating Post-Menopausal Osteoporosis with Liver and Kidney Yin Deficiency Type[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2024,32(11):11-15+20.[doi:10.20085/j.cnki.issn1005-0205.241103]
点击复制

髓三脏汤治疗肝肾阴虚型绝经后骨质疏松症的临床疗效评价()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第32卷
期数:
2024年11期
页码:
11-15+20
栏目:
临床研究
出版日期:
2024-11-15

文章信息/Info

Title:
Clinical Efficacy of Suisanzang Decoction in Treating Post-Menopausal Osteoporosis with Liver and Kidney Yin Deficiency Type
文章编号:
1005-0205(2024)11-0011-05
作者:
黄伟东1; 廖佳2; 潘柄丞3; 刘双华3; 蔡泽鹏1; 吴栓4 △; 张旭桥1△
1北京中医药大学深圳医院(龙岗)(广东 深圳,518172)
2广州中医药大学
3暨南大学中医学院
4广东省中西医结合医院
Author(s):
HUANG Weidong1; 2; LIAO Jia2; PAN Bingcheng3; LIU Shuanghua3; CAI Zepeng1; WU Shuan4△; ZHANG Xuqiao1△
1Shenzhen Hospital of Beijing University of Chinese Medicine(Longgang),Shenzhen 518172,Guangdong China; 2Guangzhou University of Chinese Medicine,Guangzhou 510006,China; 3College of Traditional Chinese Medicine of Jinan University,Guangzhou 510632,China; 4Guangdong Hospital of Integrated Traditional Chinese and Western Medicine,Foshan 528253,Guangdong China.
关键词:
髓三脏汤;  绝经后骨质疏松症;  疗效评价
Keywords:
Suisanzang decoction;  postmenopausal osteoporosis;  efficacy evaluation
分类号:
R274.31
DOI:
10.20085/j.cnki.issn1005-0205.241103
文献标志码:
A
摘要:
目的:评价髓三脏汤对肝肾阴虚型绝经后骨质疏松患者的临床疗效。方法:将72例符合纳入标准的绝经后骨质疏松患者随机分为对照组和观察组,对照组予碳酸钙D3片、骨化三醇丸口服,观察组在对照组基础上加用髓三脏汤口服。两组均治疗3个月,比较两组患者干预前后骨密度、骨代谢指标及中医症候评分、疼痛评分。结果:对照组有效率为83.33%,观察组有效率为97.22%,观察组治疗效果明显优于对照组,差异有统计学意义(P<0.05)。观察组改善疼痛评分和中医症候评分高于对照组,差异有统计学意义(P<0.01)。两组治疗后观察组患者骨钙素总体上升水平高于对照组,差异有统计学意义(P<0.05)。结论:髓三脏汤治疗绝经后骨质疏松表现出较好的临床疗效,可能存在调控骨钙素、刺激骨形成的作用。
Abstract:
Objective:To evaluate the clinical efficacy of Suisanzang decoction in treating postmenopausal osteoporosis(PMOP)patients with liver and kidney Yin deficiency type.Methods:72 post-menopausal osteoporosis patients who met the inclusion criteria were randomly divided into control group and observation group.The control group was given calcium carbonate D3 tablets and calcitriol capsules orally,while the observation group was given Suisanzang decoction orally in addition to the control group.Both groups were treated for 3 months.The bone density,bone metabolism indicators,traditional Chinese medicine syndrome scores,and pain scores between two groups before and after intervention were compared.Results:The effective rate of the control group was 83.33%,while the effective rate of the observation group was 97.22%.The treatment efficacy of the observation group was significantly better than that of the control group(P<0.05).The effect of improving pain scores and traditional Chinese medicine syndrome scores in the observation group was greater than that in the control group,with significant differences(P<0.01).After treatment,the overall increase in BGP in the observation group was greater than that in the control group(P<0.05).Conclusion:Suisanzang decoction show good clinical efficacy on the treatment of PMOP,and may have the effects of regulating BGP and stimulating bone formation.

参考文献/References:

[1] 中华医学会骨质疏松和骨矿盐疾病分会.中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(4):317-318.
[2] FERREIRA P,BATES P,DAOUB A,et al.Is bisphosphonate use a risk factor for atypical periprosthetic/peri-implant fractures?A metanalysis of retrospective cohort studies and systematic review of the current evidence[J].Orthop Traumatol Surg Res,2022,109(2):103475.
[3] BANDEIRA L,LEWIECKI E M.Anabolic therapy for osteoporosis:update on efficacy and safety[J].Arch Endocrinol Metab,2022,66(5):707-716.
[4] LV F,CAI X,YANG W,et al.Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis:systematic review and meta-analysis[J].Bone,2020,130:115121.
[5] KIRICHENKO T V,MYASOEDOVA V A,OREKHOVA V A,et al.Phytoestrogen-rich natural preparation for treatment of climacteric syndrome and atherosclerosis prevention in perimenopausal women[J].Phytotherapy Research:PTR,2017,31(8):1209-1214.
[6] 中国老年学和老年医学学会骨质疏松分会中医药专家委员会,福建省中医药科学院,福建中医药大学,等.中医药防治原发性骨质疏松症专家共识(2020)[J].中国骨质疏松杂志,2020,26(12):1717-1725.
[7] 中华中医药学会.绝经后骨质疏松症(骨痿)中医药诊疗指南(2019年版)[J].中医正骨,2020,32(2):1-13.
[8] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002.
[9] 邢振龙,李剑,丘青中,等.“肝-脾-肾”三脏一体辨证理论在膝骨关节炎治疗中的应用[J].中医正骨,2018,30(2):31-32.
[10] 吴栓,邢振龙,黄辉文,等.基于“三脏一体”辨证理论治疗膝骨性关节炎疗效分析[J].中国中医骨伤科杂志,2014,22(3):22-24.
[11] 曹盼举,张晓刚,王志鹏,等.中医古籍对骨质疏松症病因病机及治则的认识探析[J].中医药信息,2018,35(5):31-34.
[12] 娄志杰,韩向莉,孙勤,等.骨质疏松症中医证型实质的研究思路[J].时珍国医国药,2007,18(12):3093-3094.
[13] 曾远兵,蓝江滔,丘青中,等.运用“三脏一体观”治疗髋部脆性骨折术后患者的疗效分析[J].广州中医药大学学报,2019,36(5):649-652.
[14] 李晓声,李益亮,马文元,等.孙达武教授临证七十载学术思想述要:骨伤名师孙达武学术思想与临床经验研究(一)[J].湖南中医药大学学报,2022,42(5):701-704.
[15] 马艳春,范楚晨,冯天甜,等.茯苓的化学成分和药理作用研究进展[J].中医药学报,2021,49(12):108-111.
[16] 柳威,邓林华,赵英强.白术及其有效成分药理作用概述[J].中医药学报,2021,49(10):116-119.
[17] 张玉龙,王梦月,杨静玉,等.炙甘草化学成分及药理作用研究进展[J].上海中医药大学学报,2015,29(3):99-102.
[18] 《中国骨质疏松杂志》骨代谢专家组.骨代谢生化指标临床应用专家共识(2023修订版)[J].中国骨质疏松杂志,2023,29(4):469-476.

更新日期/Last Update: 2024-11-05